Net profit of Granules India declined 4.79% to Rs 97.23 crore in the quarter ended September 2024 as against Rs 102.12 crore during the previous quarter ended September 2023. Sales declined 19.48% to Rs 956.52 crore in the quarter ended September 2024 as against Rs 1188.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales956.521188.00 -19 OPM %21.2617.93 - PBDT180.91188.54 -4 PBT128.38136.02 -6 NP97.23102.12 -5 Powered by Capital Market - Live News

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) 100 mg, 150 mg, and 200 mg filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company. Bupropion Hydrochloride Extended-Release Tablets USP (SR) are bioequivalent and therapeutically equivalent to Wellbutrin SR Sustained-Release Tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC. This is a widely prescribed medication for the treatment of major depressive disorder and for the prevention of seasonal affective disorder. Granules now has a total of 67 ANDA approvals from the US FDA.Powered by Capital Market - Live News

Granules India will hold a meeting of the Board of Directors of the Company on 6 November 2024.Powered by Capital Market - Live News

Granules India unveiled its Mobile Cancer Screening Unit at AIG Hospitals. This initiative, spearheaded by the Granules Trust in partnership with Asian Medical Foundation, UC Breast Foundation and AIG Hospitals aims to enhance cancer detection and treatment in underserved communities. The state-of-the-art mobile unit Breast Health Express, brings advanced medical technology directly to communities in need. Equipped with cutting-edge mammography and ultrasound capabilities, as well as facilities for essential health checks such as haemoglobin, blood pressure, and glucose levels, this mobile clinic marks a major advancement in equitable and accessible healthcare. By offering these critical services and free medicine distribution, the initiative seeks to revolutionize cancer screening, with a particular emphasis on early breast cancer detection.Timed to coincide with Breast Cancer Awareness Month in October, the Breast Health Express aligns seamlessly with the global focus on breast cancer prevention and early detection. The mobile unit is set to commence operations in and around Hyderabad, with plans to expand to additional districts of Telangana in the coming monthsPowered by Capital Market - Live News

Granules India announced the completion of USFDA inspection of its Gagillapur FD facility with six observations. The inspection was conducted from 26 August 2024 to 06 September 2024. Powered by Capital Market - Live News